GAD-Alum (Diamyd)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GAD-Alum (Diamyd), covering 2020-04-27 to 2020-04-27. Get the full timeline:
Most recent: Clinical Trial Update: GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1) [Phase 1]